News >

Novartis to Add Lutathera to Portfolio in Planned $3.9-Billion Deal

Jason Harris
Published: Monday, Oct 30, 2017

Bruno Strigini

Bruno Strigini
Novartis has announced a planned .9-billion acquisition of Advanced Accelerator Applications (AAA), a radiopharmaceutical company that develops, produces, and commercializes Molecular Nuclear Medicines.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication